Kalamazoo, Michigan - July 26, 2012 - Stryker Corporation (NYSE:SYK) announced today that it will host an Analyst Meeting on Thursday, September 6, 2012, at 9:00 a.m. Eastern Time, in Mahwah, New Jersey.
Curt Hartman, Interim Chief Executive Officer and Vice President and Chief Financial Officer, will host the meeting with presentations by leaders of the Company's key business units.
A simultaneous webcast of the meeting will be available on Stryker's website at www.stryker.com via the For Investors page. The webcast will be archived on this site for 90 days. To hear the meeting via telephone, dial 866-362-4820 (domestic) or 617-597-5345 (international) and enter passcode 86649804.
A recording of the meeting will be available from 11:00 a.m. Eastern Time, on September 6, 2012, until 11:59 p.m. Eastern Time, on September 13, 2012. To hear this recording, dial 888-286-8010 (domestic) or 617-801-6888 (international) and enter passcode 54847232.
Certain statements made in this presentation may contain information that includes or is based on forward-looking statements within the meaning of the federal securities law that are subject to various risks and uncertainties that could cause the Company's actual results to differ materially from those expressed or implied in such statements. Such factors include, but are not limited to: weakening of economic conditions that could adversely affect the level of demand for the Company's products; pricing pressures generally, including cost-containment measures that could adversely affect the price of or demand for the Company's products; changes in foreign exchange markets; legislative and regulatory actions; unanticipated issues arising in connection with clinical studies and otherwise that affect U.S. Food and Drug Administration approval of new products; changes in reimbursement levels from third-party payors; a significant increase in product liability claims; resolution of tax audits; changes in financial markets; changes in the competitive environment; the Company's ability to integrate acquisitions; and the Company's ability to realize anticipated cost savings as a result of workforce reductions and other restructuring activities. Additional information concerning these and other factors are contained in the Company's filings with the U.S. Securities and Exchange Commission, including the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q.
Stryker is one of the world's leading medical technology companies and is dedicated to helping healthcare professionals perform their jobs more efficiently while enhancing patient care. The Company offers a diverse array of innovative medical technologies, including reconstructive, medical and surgical, and neurotechnology and spine products to help people lead more active and more satisfying lives. For more information about Stryker, please visit www.stryker.com.
Contacts
For investor inquiries please contact:
Katherine A. Owen, Stryker Corporation, 269-385-2600 or katherine.owen@stryker.com